Jennifer Howell Welle, DO
Obstetrics · Tucson, AZNPI 1609040518
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,271 of the $32,631 with a category attached, or 89.7%. Organon accounts for 64.2% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2024 at $8,660 and has fallen 70.3% since, to $2,568 in 2025. Among obstetrics clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $185.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$21K
- Merck$9K
- Hologic Sales And Service, LLC$1K
- AbbVie$454
- Biogen$202
- Astellas Pharma US Inc$157
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$29,27190%
- Food & beverage$3,33110%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 24 | $20,946 |
| Merck | 18 | $8,668 |
| Hologic Sales And Service, LLC | 29 | $1,122 |
| AbbVie | 24 | $454 |
| Biogen | 11 | $202 |
| Astellas Pharma US Inc | 7 | $157 |
| Myovant Sciences Inc. | 11 | $156 |
| Bayer | 7 | $156 |
| Sumitomo Pharma America, Inc. | 5 | $97 |
| Therapeuticsmd, Inc. | 7 | $94 |
| Coopersurgical, Inc. | 3 | $82 |
| Boston Scientific | 4 | $77 |
| Daiichi Sankyo Inc. | 5 | $67 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| Exeltis, USA Inc. | 3 | $42 |
| Aspira Women's Health Inc | 2 | $36 |
| Pfizer | 2 | $35 |
| Momentis Surgical Inc. | 1 | $30 |
| AMAG Pharmaceuticals, Inc. | 2 | $29 |
| Lupin Inc. | 2 | $28 |
| Intuitive Surgical | 1 | $25 |
| BD | 1 | $21 |
| Smith+Nephew | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $12 |
| Trevena, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$25,146
- ACESSA PROVU SYSTEM$249
- Myosure$125
- NovaSure$125
How this compares
$32,631 in reported general payments places this provider in the 95th percentile of 23 obstetrics providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 40 | $3,022 |
| Acyclovir | 24 | $391 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Tucson
- Jose RiosTucson$588
- Amanda McWhirterTucson$508
- Christinne CanelaTucson$165
- Elya ShowalterTucson$23
- Kevin HookerLake Havasu City$27K
- Katie GroffGlendale$4K
- Hannah TildenPhoenix$4K
- Chloe WoodPhoenix$3K
- Hetal ShahPhoenix$3K
- James FoltzPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.